Overview

A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This retrospective study will assess the sustained virologic response and the safety of two different interferons (pegylated or conventional) in patients with chronic hepatitis C. Data will be collected for 24 weeks.
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Interferon-alpha
Interferons
Peginterferon alfa-2a
Peginterferon alfa-2b
Ribavirin